As of 2025-05-21, the EV/EBITDA ratio of Green Cross Medical Science Corp (142280.KQ) is 17.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 142280.KQ's latest enterprise value is 101,786.90 mil KRW. 142280.KQ's TTM EBITDA according to its financial statements is 5,961.07 mil KRW. Dividing these 2 quantities gives us the above 142280.KQ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 5.6x - 8.6x | 6.5x |
| Forward P/E multiples | 3.5x - 6.2x | 4.8x |
| Fair Price | 403.84 - 1,596.58 | 922.44 |
| Upside | -89.7% - -59.2% | -76.4% |
| Date | EV/EBITDA |
| 2025-04-17 | 16.42 |
| 2025-04-16 | 16.36 |
| 2025-04-15 | 16.35 |
| 2025-04-14 | 16.24 |
| 2025-04-11 | 15.98 |
| 2025-04-10 | 15.63 |
| 2025-04-09 | 14.98 |
| 2025-04-08 | 15.32 |
| 2025-04-07 | 15.38 |
| 2025-04-04 | 16.22 |
| 2025-04-03 | 16.09 |
| 2025-04-02 | 16.16 |
| 2025-04-01 | 16.58 |
| 2025-03-31 | 15.98 |
| 2025-03-28 | 16.29 |
| 2025-03-27 | 16.73 |
| 2025-03-26 | 17.24 |
| 2025-03-25 | 17.13 |
| 2025-03-24 | 16.91 |
| 2025-03-21 | 17.04 |
| 2025-03-20 | 16.98 |
| 2025-03-19 | 17.15 |
| 2025-03-18 | 17.49 |
| 2025-03-17 | 17.42 |
| 2025-03-14 | 17.26 |
| 2025-03-13 | 16.87 |
| 2025-03-12 | 16.98 |
| 2025-03-11 | 16.78 |
| 2025-03-10 | 16.98 |
| 2025-03-07 | 16.73 |
| 2025-03-06 | 16.75 |
| 2025-03-05 | 16.77 |
| 2025-03-04 | 16.55 |
| 2025-02-28 | 16.95 |
| 2025-02-27 | 16.93 |
| 2025-02-26 | 17.26 |
| 2025-02-25 | 16.91 |
| 2025-02-24 | 17.08 |
| 2025-02-21 | 16.29 |
| 2025-02-20 | 16.15 |
| 2025-02-19 | 16.13 |
| 2025-02-18 | 16.09 |
| 2025-02-17 | 16.04 |
| 2025-02-14 | 15.98 |
| 2025-02-13 | 16.09 |
| 2025-02-12 | 16.13 |
| 2025-02-11 | 16.20 |
| 2025-02-10 | 16.20 |
| 2025-02-07 | 16.15 |
| 2025-02-06 | 16.46 |